Form D · Biotechnology
OncoResponse, Inc
Houston, TX · CIK 0001655774
Offering snapshot reported May 6, 2025 · SEC filing
- Reported sold
- $6M Indefinite offering
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 6, 2025 | Initial | $5,999,138 | No comparison | 9 | SEC filing |
| May 12, 2023 | Initial | $13,915,153 | No comparison | 13 | SEC filing |
| Mar 31, 2021 | Initial | $40,625,995 | No comparison | 14 | SEC filing |
| Sep 6, 2018 | Initial | $18,999,999 | No comparison | 12 | SEC filing |
| Mar 23, 2017 | Amendment | $29,499,000 | $10,000,000vs May 26, 2016 | 12 | SEC filing |
| May 26, 2016 | Amendment | $19,499,000 | $3,000,000vs Oct 15, 2015 | 8 | SEC filing |
| Oct 15, 2015 | Initial | $16,499,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-545368
Source: Form D, filed May 6, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alice Bexon | Executive |
| Roberto De Ponti | Director |
| Carol Gallagher | Director |
| Steven Gillis | Director |
| Steve Gillis | Director |
| Alan Ginsberg | Director |
| Russ Hawkinson | Executive |
| Patrick Joseph Hojlo | Director |
| Wende Hutton | Director |
| Nathan Jorgensen | Director |
| Ted Koutouzis | Director |
| Robert J. Lechleider | Executive |
| Bob Lechleider | Executive |
| Sean A. Mc Carthy | Director |
| John Mc Kearn | Director |
| Andrew Perlman | Director |
| Kamal D. Puri | Executive |
| Chris Russell | Executive |
| Christopher A. Russell | Executive |
| Clifford J. Stocks | Director, Executive |
| Kristine Swiderek | Executive |
| Geeta Vemuri | Director |
| Daguang Wang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
609 Main Street Suite 4200
Houston, TX, 77002
Houston, TX, 77002